Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Completed

• Conditions: COVID; SARS-CoV 2

• Registration Number: NCT04408014
• Lead Sponsor: Butantan Institute

Brief Summary

Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo

Detailed Description

This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo

Study Timeline

• Study First Submitted: 2020-05-22
• Study First Submitted QC: 2020-05-27
• Study First Posted: 2020-05-29
• Study Start: 2020-06-01
• Primary Completion: 2020-07-15
• Study Completion: 2020-07-30
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-14
• Last Update Posted: 2024-02-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 18901

Inclusion Criteria

• All potential volunteers invited to participate in the study.

Exclusion Criteria

• All potential eligible participants, but who do not show interest in participating in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of antibodies against SARS-CoV-2 through serological testing	1 month	IgM and IgG antibodies against SARS-CoV-2
Frequency of participants with a positive RT-PCR test result for SARS-CoV-2	1 month	Positive RT-PCR test result for SARS-CoV-2

Trial Locations

Locations (1)

Avenida Vital Brasil 1500; 🇧🇷 Sao Paulo, Brazil